An international multi-centre, randomised, double-blind, placebo controlled trial to evaluate the efficacy and safety of 0.5% and 2% Pro 2000/5 gels for the prevention of vaginally acquired human immunodeficiency virus (HIV) infections

http://isrctn.org/> ◽

10.1186/isrctn64716212 ◽

2012 ◽

Author(s):

Sheena McCormack

Keyword(s):

Human Immunodeficiency Virus ◽

Controlled Trial ◽

Hiv Infections ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Immunodeficiency Virus

Download Full-text

A randomized, double-blind, placebo-controlled trial and open-label extension study to evaluate the efficacy and safety of pregabalin in the treatment of neuropathic pain associated with human immunodeficiency virus neuropathy

Pain ◽

10.1016/j.pain.2014.05.027 ◽

2014 ◽

Vol 155 (10) ◽

pp. 1943-1954 ◽

Author(s):

David M. Simpson ◽

Andrew S.C. Rice ◽

Birol Emir ◽

Jaren Landen ◽

David Semel ◽

...

Keyword(s):

Human Immunodeficiency Virus ◽

Neuropathic Pain ◽

Controlled Trial ◽

Extension Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Immunodeficiency Virus ◽

Open Label Extension

Download Full-text

Cerebrospinal and peripheral human immunodeficiency virus type 1 load in a multisite, randomized, double-blind, placebo-controlled trial ofd-Ala1-peptide T-amide for HIV-1-associated cognitive-motor impairment

Journal of NeuroVirology ◽

10.1080/13550280600827344 ◽

2006 ◽

Vol 12 (3) ◽

pp. 178-189 ◽

Author(s):

Karl Goodkin ◽

Benedetto Vitiello ◽

William D Lyman ◽

Deshratn Asthana ◽

J Hampton Atkinson ◽

...

Keyword(s):

Human Immunodeficiency Virus ◽

Human Immunodeficiency Virus Type ◽

Controlled Trial ◽

Motor Impairment ◽

Double Blind ◽

Double Blind Placebo ◽

Immunodeficiency Virus ◽

Download Full-text

RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF DITIOCARB SODIUM ('IMUTHIOL') IN HUMAN IMMUNODEFICIENCY VIRUS INFECTION

10.1016/s0140-6736(88)90184-5 ◽

1988 ◽

Vol 332 (8613) ◽

pp. 702-706 ◽

Author(s):

J LANG

Keyword(s):

Human Immunodeficiency Virus ◽

Virus Infection ◽

Human Immunodeficiency Virus Infection ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Immunodeficiency Virus

Download Full-text

Randomized double-blind, placebo-controlled trial of twice-daily zidovudine in asymptomatic haemophiliacs infected with the human immunodeficiency virus type 1

British Journal of Haematology ◽

10.1111/j.1365-2141.1994.tb03270.x ◽

1994 ◽

Vol 86 (1) ◽

pp. 174-179 ◽

Author(s):

P. M. Mannucci ◽

A. Gringeri ◽

G. Savidge ◽

P. Gatenby ◽

Y. Laurian ◽

...

Keyword(s):

Human Immunodeficiency Virus ◽

Human Immunodeficiency Virus Type ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Immunodeficiency Virus

Download Full-text

A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment

Neurology ◽

10.1212/wnl.50.3.645 ◽

1998 ◽

Vol 50 (3) ◽

pp. 645-651 ◽

Author(s):

Keyword(s):

Human Immunodeficiency Virus ◽

Cognitive Impairment ◽

Controlled Trial ◽

Thioctic Acid ◽

Double Blind ◽

Double Blind Placebo ◽

Immunodeficiency Virus

Download Full-text

Zidovudine Treatment in Patients with Primary (Acute) Human Immunodeficiency Virus Type 1 Infection: A Randomized, Double-Blind, Placebo-Controlled Trial

The Journal of Infectious Diseases ◽

10.1086/515612 ◽

1998 ◽

Vol 178 (1) ◽

pp. 80-91 ◽

Author(s):

M. T. Niu ◽

J. Bethel ◽

M. Holodniy ◽

H. C. Standiford ◽

S. M. Schnittman ◽

...

Keyword(s):

Human Immunodeficiency Virus ◽

Human Immunodeficiency Virus Type ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Zidovudine Treatment ◽

Immunodeficiency Virus

Download Full-text

The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type I (HIV) infection: A double-blind, placebo-controlled trial

American Journal of Infection Control ◽

10.1016/0196-6553(91)90009-2 ◽

1991 ◽

Vol 19 (4) ◽

pp. 218

Keyword(s):

Human Immunodeficiency Virus ◽

Hiv Infection ◽

Human Immunodeficiency Virus Type ◽

Controlled Trial ◽

Type I ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Immunodeficiency Virus ◽

Symptomatic Human Immunodeficiency Virus

Download Full-text

The Safety and Efficacy of Adefovir Dipivoxil, a Novel Anti‐Human Immunodeficiency Virus (HIV) Therapy, in HIV‐Infected Adults: A Randomized, Double‐Blind, Placebo‐Controlled Trial

The Journal of Infectious Diseases ◽

10.1086/514150 ◽

1997 ◽

Vol 176 (6) ◽

pp. 1517-1523 ◽

Author(s):

Steven G. Deeks ◽

Ann Collier ◽

Jacob Lalezari ◽

Andrew Pavia ◽

Daniel Rodrigue ◽

...

Keyword(s):

Human Immunodeficiency Virus ◽

Adefovir Dipivoxil ◽

Controlled Trial ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Hiv Therapy ◽

Immunodeficiency Virus

Download Full-text

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PSYCHOSTIMULANTS FOR THE TREATMENT OF FATIGUE IN AMBULATORY PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS DISEASE

Infectious Diseases in Clinical Practice ◽

10.1097/00019048-200103000-00025 ◽

2001 ◽

Vol 10 (3) ◽

pp. 173

Author(s):

&NA;

Keyword(s):

Human Immunodeficiency Virus ◽

Virus Disease ◽

Controlled Trial ◽

Human Immunodeficiency Virus Disease ◽

Double Blind ◽

Double Blind Placebo ◽

Immunodeficiency Virus ◽

Ambulatory Patients

Download Full-text

A Randomized, Double-blind, Placebo-Controlled Trial of Psychostimulants for the Treatment of Fatigue in Ambulatory Patients With Human Immunodeficiency Virus Disease

Archives of Internal Medicine ◽

10.1001/archinte.161.3.411 ◽

2001 ◽

Vol 161 (3) ◽

pp. 411 ◽

Author(s):

William Breitbart ◽

Barry Rosenfeld ◽

Monique Kaim ◽

Julie Funesti-Esch

Keyword(s):

Human Immunodeficiency Virus ◽

Virus Disease ◽

Controlled Trial ◽

Human Immunodeficiency Virus Disease ◽

Double Blind ◽

Double Blind Placebo ◽

Immunodeficiency Virus ◽

Ambulatory Patients

Download Full-text